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Secnidazole is a medicine widely used in the treatment of bacterial and protozoal diseases. The free sale of this drug allows its
easy access to the population and for this reason, the studies that involve the analysis of the quality control of this drug are
extremely important to keep the results safe and reliable. Considering the great pharmacotherapeutic application of secnidazole
and the great importance of developing new analytical methods that contribute to the environment, the study was based on the
development and validation of a new sustainable analytical method by Fourier-transform infrared spectroscopy (FT-IR) to identify
and quantify secnidazole  tablets.  The method was validated according to the ICH guidelines,  presenting precision, accuracy,
selectivity, robustness and linearity in the concentration range of 0.5-1.3 mg/pellet. The application of this method in addition to
being safe and reliable is highly favorable from an economic point of view since that present speed analysis, lower economic costs
and significant reduction of the solvents with minimal or no pre-treatment in the samples, being fast and simple and can also be
applied to other medicines.
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Introduction
Secnidazole  (Figure  1)  is  a  drug  with  broad-spectrum
activity against anaerobic protozoa and many anaerobic and
microaerophilic bacteria  which belongs to the group of 5-
nitroimidazoles,  it  is  chemically  designated,  according  to
IUPAC,  as  (RS)  -1-  (2-methyl-5-nitro-1H-imidazol-21-yl)
propan-2-ol (1).
Figure 1. Chemical structure of secnidazole (CAS 3366-95-8).
The nitro group in its chemical structure leads to the action
of  the  drug  when  it  suffers  a  reduction  after  the  drug
penetration  by  microorganism  diffusion.  In  the  case  of
parasites, such reduction occurs by the pyruvate-ferridoxin
pathway (2).
In the literature, it was found many analytical methods for
the quantification of secnidazole by HPLC (3-9) and UV-Vis
spectroscopy  (10-13).  However,  these  methods  use  large
quantities of toxic solvents, buffer solutions in mobile phase
and  production  of  high  levels  of  waste,  which  is  not
interesting for environmental preservation and because they
are against the principles of green analytical chemistry.
In  the  literature,  the  IR  spectroscopy  is  considered  an
excellent  method  for  identification  of  drugs  and
pharmaceutical  medicines,  but  recent  studies  demonstrate
that  this  technique  also  can  be  used  for  quantification  of
substances.  It  contemplates the green chemistry because it
only  uses  potassium  bromide  as  reagent,  promoting
advantages as low cost, low generation of toxic waste and no
use of organic solvents (14). IR technique also have others
advantages as low analysis time, simplicity in the execution
and possibility of the analysis of insoluble material  in the
commonly used solvents for preparing solutions for another
analysis techniques (15). 
Fourier-transform  infrared  spectroscopy  (FT-IR)  is  a
technique widely used by industries and laboratories because
it is more sensitive and faster than the dispersive infrared
spectrometer,  because  it  measures  energy  at  one  time
absorbed to sample at each wavelength through a beam of
transmitted infrared light. (16-28).
Thus, the purpose of our paper is to develop and validate a
new analytical  method for quantification of secnidazole in
tablet  using the infrared  technique and contributing to the
drug  quality  control  by  introducing  an  environmentally
friendly method.
Experimental
Chemicals and reagents
Secnidazole reference chemical substance (RCS) with purity
content of 99.63% and sample (tablets containing 1.000 mg
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secnidazole)  were  kindly  provided  by  the  EMS
pharmaceutical company (Hortolândia, SP, Brazil).
Potassium bromide  (BrK)  (Synth,  Brazil)  used  for  pellets
preparation was analytical grade. To obtain the pellets, BrK
was powdered and dried to constant weight at 105°C. 
Equipment
An  FT-IR  spectrometer  (Shimadzu®,  Kyoto,  Japan,  IR
Prestige-21 model) was used to obtain the spectrums in the
region  of  4000-500 cm-1 at  intervals  of  2  cm-1.  The  band
corresponding  to  nitro  group in the molecule  of  drug was
selected  using  the  support  of  IR  Solution  software,  which
was consisted in the spectral region between 1560-1350 cm-1.
Obtaining of analytical curve
Equivalent  amounts  of  0.5,  0.7,  0.9,  1.1  and  1.3  mg  of
secnidazole were previously diluted in BrK (1:10 w/w) and
after this, the samples were diluted in BrK again to obtain
enough quantities  of  150  mg of  pellets.  After  adding  the
powders,  the  homogeneous  mixture  was  submitted  to
mechanical  pressure  of  85 kN for  10 minutes,  to  prepare
translucent pellets.
Preparation of secnidazole RCS pellets
Aliquots of powder equivalent to 0.9 mg of secnidazole RCS
were diluted with BrK in a ratio of 1:10 (w/w) and after this,
the mixture were  properly homogenized in 141 mg BrK to
form translucent pellets of 150 mg. The determinations of
the substance were performed in triplicate and the readings
were performed in absorbance.
Preparation of secnidazole tablets pellets
First, the mean weight of twenty tablets of secnidazole 1 g
was determined according to the Brazilian Pharmacopoeia,
2010 (29). Aliquots equivalent to 0.9 mg secnidazole were
weighed and diluted with BrK in a ratio of 1:10 (w/w) and
after  this,  were  homogenized  in  141  mg  BrK,  to  form
translucent  pellets  of  150  mg.  The  determinations  of  the
substance were performed in triplicate and the readings were
performed in absorbance.
Preparation of adjuvants present in secnidazole tablets
A mixture of adjuvants present in the tablets of secnidazole
was  performed  in  the  usual  concentrations  to  assess  the
possibility of interference in spectrophotometric analysis of
secnidazole in the infrared region. All the adjuvants, being
microcrystalline  cellulose,  maize  starch,  hypromellose,
purified  water,  polyethylene  glycol,  sodium  starch
glycollate,  povidone,  magnesium  stearate,  colloidal
anhydrous silica and isopropyl alcohol, were homogenized
and diluted 1:10 in BrK for the formation of pellets of 150
mg. The determinations of the substances were performed in
triplicate and the readings were performed in absorbance.
Method validation
The  method  was  validated  according  to  the  International
Conference on Harmonisation guidelines showing: accuracy,
linearity,  precision,  robustness,  selectivity  and  limits  of
detection and quantification.
Linearity
To validate the method, it was used five concentrations (0.5,
0.7, 0.9, 1.1 and 1.3 mg) of secnidazole to obtain the curve.
The  linearity  of  the  method  was  evaluated  by  linear
regression  analysis,  which  is  calculated  by  the  square
minimum  method  and  the  statistical  analysis  was  by
ANOVA. The linearity was carried out in three days. 
Selectivity
The  selectivity  of  the  method  was  performed  to  certify
whether  the  presence  of  the  adjuvants  present  in  the
secnidazole  tablets  were  not  able  to  interfere  in  the
quantification  of  the  drug.  For  this  parameter,  the
measurements were performed in triplicate and the spectra
were overlapping.
Precision
The precision of the method was obtained by two different
criteria:  repeatability  (intraday  precision)  and  intermediate
(interdays precision and between analyst precision).
The  repeatability  precision  was  performed with  the
preparation of six secnidazole pellets at a concentration of
0.9 mg/150 mg pallets, on the same day and under the same
working conditions.  The intermediate  precision (interdays)
was  carried  out  by  the  same  analytical  conditions  to
repeatability, but in three different days and the intermediate
precision  (between  analysts)  was  performed by  another
analyst, but under the same working conditions, which were
calculated  by  the relative  standard  deviation  (RSD),
ANOVA and student´s t-test respectively. 
Accuracy
Accuracy  was evaluated  according  to  the  recovery  test  in
which known  amount  of  standard  was  added  in  known
quantity of sample (ICH, 2005) in three concentration levels
(R1, R2, R3), which were performed in  triplicate on three
different days. Table 1 shows the preparation of the tablets
for the recovery test method.
Table 1. Preparation of pellets for the test of recovery of FT-IR
method for secnidazole.
Secnidazole
sample (mg)
(dilution
1:10, w/w in
BrK)
Secnidazol
e standard
(mg)
(dilution
1:10, w/w
in BrK)
%
Final
theorical
concentration
(mg/pellets)
BrK
amount
(mg)
Sample 0.50 --- 0.50 145.00
R1 0.50 0.22 80 0.72 142.80
R2 0.50 0.40 100 0.90 141.00
R3 0.50 0.58 120 1.08 139.20
Standard ---- 0.50 0.50 145.00
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Robustness
This parameter is important to show that the validity of the
method  is  maintained  even  with  small  variations  in  the
method  ́s  working  conditions.  For  evaluation  of  the
robustness,  individual  modifications  were  made  to  the
established experimental conditions, such as: the potassium
bromide  (BrK)  source,  the  compression  time  and  the
compression  strength  to  produce  the  pellet.  The  obtained
responses were statistically analyzed using student's t-test to
evaluate the effects of the modifications.
Detection and Quantitation limits
The limits of detection and quantification were based and
calculated  according  to  the  standard  deviation  and
intersection  curve  that  were  obtained  from three  different
curves.  The values  were  calculated  using the Equations 1
and 2.
Equation 1. LOD=3.3×SD÷a
Equation 2. LOQ=10×SD÷a
Where: a = inclination of the analytical curve.
SD = intercept standard deviation.
Results and discussion
Research  and  analysis  focused  on  quality  control  of
medicines  are  extremely  important,  because  it  is  through
them that  the  results  will  guarantee  the  effectiveness  and
quality of the final products. Quality control aims to identify
the physical, chemical and biological properties of the active
products  adopting  processes  and  procedures  through
equipment, materials and systems developed (30-32). Along
with  this  and  taking  in  account  the  reduction  of
environmental  impacts  and  the  safety  of  operators  and
patients,  the  industries  would  choose  to  invest  in
ecologically  correct  methods,  such  as  infrared  (IR)
spectroscopy.
In IR spectroscopy technique, the molecule when absorbed,
presents  frequency  by infrared  radiation absorbing natural
vibrational frequency, which originates in an increase of the
amplitude of this vibration movement in the chemical bonds
of molecules (28).
Numerous  analytical  methods  have  been  found  in  the
literature  to  identify  and  quantify  secnidazole,  but  the
methods present some disadvantages when it comes to the
application  of  green  chemistry  methods  because  they  use
more expensive reagents, toxic solvents, slower production
processes and analyzes and generation of toxic waste (33-
37). 
Besides FTIR method do not use organic solvent, it presents
others  advantages  as  easy  implementation,  speed  the
analysis, lower economic cost,  minimal or no pre-treatment
in the  samples,  allowing the presence  of  impurities  when
present in the samples and providing optimal resolution and
accurate  results  in  quantitative  and  identification  analysis,
especially  in  drugs  and/or  substances  that  present
incompatibilities with solvents (16,19,20,26). 
Thus,  an  innovative  infrared  spectroscopy  method for  the
analysis of secnidazole tablets was developed and validated,
due to non-use of the organic solvent,  allowing a reliable
quantification  of  secnidazole  tablets,  being  an  excellent
alternative  method  to  the  routine  of  quality  control  in
laboratories and pharmaceutical industries. 
The method can be quantified by measuring the absorbance
of the band corresponding to the nitro group presents in the
drug molecule, in the region between 1.560 and 1.350 cm-1,
showing  accuracy,  linearity,  precision,  robustness  and
selectivity.
Linearity
The analytical curve was made on three consecutive days,
showing mean values of absorbances in the region of 1560-
1350 cm-1 in relation to concentrations between 0.5 to 1.3
mg/pellet as shown in Figure 2. The correlation coefficient
(r)  was  of  0.9985  and  statistical  analysis  (Table  2)  was
calculated by ANOVA and the calculated showed (p <0.05),
F calculated (3.34) lower than F critical (3.71), showing the
linearity of the method (38). 
 
Figure  2.  Graphical  representation  of  the  analytical  curve  of
secnidazole by FT-IR method.
Table 2. Analysis of variance (ANOVA) of the linearity using FT-
IR for determination of secnidazole.
Source of
variation DF
Sum of
Square Variance
F
calculated
F
critical
Between 
concentrations 4 0.50205 0.12551 492.85* 3.48
Linear 
regression 1 0.49950 0.49950 1961.39* 4.96
Linear 
deviations 3 0.00255 0.0008494 3.34 3.71
Residue 10 0.00255 0.0002547 - -
Total 14 0.50460 - - -
Selectivity
The adjuvants present in the tablets of secnidazole did not
show  specific  absorption  bands.  Thus,  there  is  no
interference with the results obtained for the quantification
of the drug, as shown in Figure 3.
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Figure  3.  Overlap  absorption  spectra  in  the  infrared  region
secnidazole  CRS  (in  red),  secnidazole  tablets  (in  blue)  and
adjuvants (in black).
Precision
The  repeatability  precision  of  the  analytical  method  was
considered reliable due the value obtained of RSD have been
low  (<5.0).  The  intermediate  precision  (interdays  and
between analysts) was performed by two analysts, ANOVA
and  student´s t-test,  respectively,  and  comprove  the
precision of the method due the values calculated of  t or F
were  lower  than the  values  critical  of  t or  F.  The results
found for the precision parameter are presented in Table 3.
Table 3. Determination of the precision of the FT-IR method for
analysis of secnidazole.
Repeatability Intermediate
Intraday
precision
Interdays precision Between analyst
precision
Average =
0.464* Test F
Fcalc 1.48 < Fcrit 3.10 Fcalc 1.29 < Fcrit 5.05
RSD (%) =
2.56** Valor-P = 0.26 Test t
tcalc 1.11 < tcrit 2.22
*Average  of  six  determinations  **Relative  Standard  Deviation  of  six
determinations
Accuracy
The accuracy was carried out by recovery test that presented
adequate  values,  obtaining  rates  very  close  to  100%
recoveries,  showing the  accuracy  of  the  method.  Table  4
shows the data obtained in the recovery test.
Table 4. Determination of the accuracy  of the FT-IR method for
analysis of secnidazole.
Secnidazole
SCR
added
(mg)
Secnidazole
SCR
founded
(mg)
Recovery
(%)
RSD
(%)
Average
recovery
(%)
R1 0.220 0.219 99.93 1.59
R2 0.440 0.399 99.99 1.60 99.53
R3 0.580 0.572 98.66 0.48
Robustness
The effects of each modification in the potassium bromide
(BrK)  source,  the  compression  time  and  compression
strength to make the pellets were evaluated by student´s t-
test. The method was considered robust due do not present
statistically  significant  difference,  since  t calculated  value
was  lower  than  t critical  value,  except  for  compression
pressure,  which  means  that  caution  must  be  taken  at  this
point, as shown in Table 5.
Table  5.  Results  of  Student´s t test  for  robustness  of  the
spectrophotometry  in  the infrared region method for  analysis  of
secnidazole.
Conditions
Absorbance
s with
normal
conditions *
Absorbances
with changed
conditions *
Test-F:
two
samples
for
variance
Test-t: two
samples
assuming
equal
variances
Potassium
bromide
(BrK) mark
0.425 0.410
F cal
1.01 <
19.0 F
crit
p value
0.50>
0.05
t cal 0.32
< 2.78 t
crit
p value
0.76 >
0.05
Compression
time 0.425 0.444
F cal
2.05 <
19.0 F
crit
p value
0.33 >
0.05
t cal 1.58
< 2.78 t
crit
p value
0.19 >
0.05
Compression
strength 0.425 0.494
F cal
7.04 <
19.0 F
crit
p value
0.12 >
0.05
t cal 6.39
> 2.78 t
crit
p value
0.003 <
0.05
Detection and Quantitation limits
The  limits  of  detection  (LOD)  and  quantification  (LOQ)
were calculated to determine the sensitivity of the method.
The value found for the LOD was 0.094 mg and the LOQ
was 0.284 mg, which indicates the reliability of the method
for  the  determination  and  quantification  of  secnidazole
tablets 1.000 mg in the concentration range chosen.
Conclusions
In  this  work,  it  was  validated  a  method  using  Fourier-
transform infrared spectroscopy (FT-IR) for quantitation of
secnidazole  tablets.  All  validation  parameters  were
satisfactory,  indicating  linearity,  selectivity,  precision,
accuracy  and robustness.  In  addition,  the method presents
advantagens  over  the  existent  methods  for  analysis  of
secnidazole  due  its  simplicity  of  execution,  low  cost,
absence  of  organic  solvents,  minimal  preparation  of
samples, with low waste generation and high safety operator.
Therefore, this method can be a great alternative in routine
analysis  for  secnidazole  tablets,  as  well  as  this  study
represents  the  possibility  of  application  of  FT-IR  for
quantification of drugs.
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